Drugs / ozonated oil
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04828720 | Oct 2019 → Apr 2020 | gingival disorder | Cairo University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05211622 | Mar → Dec 2022 | stomatitis | University of Palermo | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07328698 | Feb → Apr 2026 overdue | — | Nigde Omer Halisdemir University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ozonated oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05211622 ↗ |
| Route | Topical | “The wounds were coated with 2 ml ozonated oil per day” NCT04828720 ↗ |